Follow
Peter J.K. Kuppen
Peter J.K. Kuppen
Leiden University Medical Center, Dept. of Surgery
Verified email at lumc.nl
Title
Cited by
Cited by
Year
The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery
BE Schaafsma, JSD Mieog, M Hutteman, JR Van der Vorst, PJK Kuppen, ...
Journal of surgical oncology 104 (3), 323-332, 2011
9272011
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer
R Salazar, P Roepman, G Capella, V Moreno, I Simon, C Dreezen, ...
Journal of clinical oncology 29 (1), 17-24, 2011
6542011
Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
EM de Kruijf, JGH van Nes, CJH van de Velde, H Putter, VT Smit, ...
Breast cancer research and treatment 125, 687-696, 2011
3422011
Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer
JSD Mieog, SL Troyan, M Hutteman, KJ Donohoe, JR Van Der Vorst, ...
Annals of surgical oncology 18, 2483-2491, 2011
3242011
HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients
EM de Kruijf, A Sajet, JGH van Nes, R Natanov, H Putter, VT Smit, ...
The Journal of Immunology 185 (12), 7452-7459, 2010
3232010
The CpG island methylator phenotype (CIMP) in colorectal cancer
EN Mojarad, PJK Kuppen, HA Aghdaei, MR Zali
Gastroenterology and hepatology from bed to bench 6 (3), 120, 2013
3092013
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
AG Menon, CM Janssen-van Rhijn, H Morreau, H Putter, RAEM Tollenaar, ...
Laboratory investigation 84 (4), 493-501, 2004
2952004
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
PA Albertsson, PH Basse, M Hokland, RH Goldfarb, JF Nagelkerke, ...
Trends in immunology 24 (11), 603-609, 2003
2932003
Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients
E Bastiaannet, GJ Liefers, AJM De Craen, PJK Kuppen, W Van De Water, ...
Breast cancer research and treatment 124, 801-807, 2010
2802010
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization
MH Sandel, AR Dadabayev, AG Menon, H Morreau, CJM Melief, ...
Clinical Cancer Research 11 (7), 2576-2582, 2005
2472005
TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis
L Zhang, F Zhou, AG de Vinuesa, EM de Kruijf, WE Mesker, L Hui, ...
Molecular cell 51 (5), 559-572, 2013
2392013
High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue
A Ly, A Buck, B Balluff, N Sun, K Gorzolka, A Feuchtinger, KP Janssen, ...
Nature protocols 11 (8), 1428-1443, 2016
2322016
Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer
FM Speetjens, PJK Kuppen, MJP Welters, F Essahsah, ...
Clinical Cancer Research 15 (3), 1086-1095, 2009
2292009
The immunological consequences of photodynamic treatment of cancer, a literature review
FH van Duijnhoven, RIJM Aalbers, JP Rovers, OT Terpstra, PJK Kuppen
Immunobiology 207 (2), 105-113, 2003
2252003
The role of natural killer T cells in cancer—a phenotypical and functional approach
D Krijgsman, M Hokland, PJK Kuppen
Frontiers in immunology 9, 367, 2018
2222018
Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I–II colon cancer patients
WE Mesker, GJ Liefers, J Junggeburt, GW van Pelt, P Alberici, ...
Analytical Cellular Pathology 31 (3), 169-178, 2009
1852009
Specific tumor-cell killing with adenovirus vectors containing the apoptin gene
AM Pietersen, MM Van der Eb, HJ Rademaker, DJM Van den Wollenberg, ...
Gene Therapy 6 (5), 882-892, 1999
1841999
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
ECM Zeestraten, MS Reimers, S Saadatmand, JWT Dekker, GJ Liefers, ...
British journal of cancer 110 (2), 459-468, 2014
1832014
Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry
A Trinh, K Trumpi, F De Sousa E Melo, X Wang, JH De Jong, E Fessler, ...
Clinical cancer research 23 (2), 387-398, 2017
1672017
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
EM de Kruijf, A Sajet, JGH van Nes, H Putter, VT Smit, RA Eagle, I Jafferji, ...
BMC cancer 12, 1-12, 2012
1632012
The system can't perform the operation now. Try again later.
Articles 1–20